companydata.dkcompanydata.dk

WIIK PHARMA ApS: Financial statements 2019

CVR: 36481315

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

WIIK PHARMA ApS (CVR 36481315) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,536,526 and a net result of DKK 829,924 compared with DKK 736,417 the year before. That is an increase of 18.4% compared with the year before. Equity in the 2019 report amounted to DKK 886,920. The solvency ratio was 29.9%.

Gross Profit
DKK 2,536,526
Profit/Loss
DKK 829,924
Equity
DKK 886,920
Total Assets
DKK 2,966,608

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-2.5 mio.830 t.887 t.-
2018-2.1 mio.736 t.787 t.-
2017-1.5 mio.274 t.351 t.-
2016-1.4 mio.432 t.76 t.-
2015-301 t.-406 t.-356 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

WIIK PHARMA ApS: The 2018 annual report is outApr 13, 2019

WIIK PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 2,142,630, and the net result was DKK 736,417.

About WIIK PHARMA ApS

WIIK PHARMA ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2015. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rune Wiik Kristensen. The board consists of Bernt Skov Jensen (chair), Rune Wiik Kristensen and Yacoub Youssef Ibrahim Amin. The company is owned by Yacoub Amin Invest ApS and Wiik LLC. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 7,105,582 and a net result of DKK 2,024,721 compared with DKK 4,385,191 the year before. Equity in the 2025 report amounted to DKK 6,710,672.

Source: annual report 2025, Danish Business Authority